The cannabis industry started to experience major changes thanks to the development of CBD. Most of the useful properties of CBD have not yet been proven. In the United States, where CBD is legalized, it can be found everywhere. Consequently, over the last four years, CBD sales have increased by 40%.Large cosmetic companies, such as Sephora, produce cannabis-based creams.
As the drug moves away from being taboo, more industries are taking advantage of consumer interest in the health benefits of cannabis by designing cannabis-infused products.
TechCrunch reports that American manufacturers of food, medicine, cosmetics, and other products have been increasingly adding cannabis to their products.
The rise of CBD cannabis-infused products
The cannabis industry has begun to experience a number of major changes thanks to the development of CBD.
Manufacturers have learned to separate the two major chemicals in marijuana: THC (tetrahydrocannabinol) and CBD (cannabidiol).
Non-psychotropic CBD suppresses pain and reduces anxiety without the effects of drug intoxication.
The absence of intoxication when using CBD made cannabis more attractive. So, consumers can get rid of anxiety or pain and continue to function normally.
Benefits of cannabis-infused products
Most of the useful properties of CBD have not yet been proven by scientific research but by independent experts.
Just a handful of studies suggest that cannabis is capable of treating glaucoma, epilepsy, and anxiety. Despite this, consumers are ready to buy various CBD products, starting with food, ending with cosmetics, in the hope of using them to cure insomnia, headaches or to simply help them relax.
CBD is legal in the US, as such cannabis-infused products are everywhere. Consequently, over the last four years, CBD sales have increased by 40%.
Large retailers sell candles and cannabis oils. Restaurants can buy coffee and cocktails with marijuana. Large cosmetic companies, such as Sephora, produce cannabis-based creams.
CBD regulations cause concern
The US Food and Drug Administration (FDA) and independent experts have expressed concern. Some companies make unsubstantiated statements about the effectiveness of cannabis products.
Also, other companies add less CBD than the label says, making the product untrustworthy.
The Farm Bill may have legalized hemp and CBD but there are still few regulations governing quality and companies making unreasonable health claims.
CBD companies have to retain a high level of transparency with cannabis infused-products
This means it is important that CBD companies retain a high level of transparency.
The perfect example of this is Veritas Farms Inc (OTC: VFRM). Veritas means truth in Latin and the company sticks by its name.
It operates a 140-acre industrial hemp farm in Pueblo, Colorado, and makes it simple for consumers to verify the quality of their products via innovative QR code packaging.
In Q2 2019 Veritas generated more than $2.9 million in total revenue and that is a 500% increase since Q2 2018.
In addition, their gross profits reached $1,523,413 and thanks to great results, they managed to reduce the liabilities by over $1.3 million.
This kind of rapid growth demonstrates the huge potential of the North American CBD industry. Particularly for companies that are willing to go above and beyond in order to provide a quality product for their customers.
(Featured Image by Laryssa Suaid)
This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff, or associates.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof.
First published in Investory news, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.